Please provide your email address to receive an email when new articles are posted on . Roche Diagnostics Corp. announced that the FDA has cleared its next-generation troponin T assay for use in ...

US physicians who’ve been waiting to get their hands on high-sensitivity troponin tests don’t have to wait any longer. Last week, the US Food and Drug Administration (FDA) gave 510(k) clearance to the ...

Results from the TRAPID-AMI clinical study have been published online by the Annals of Emergency Medicine, confirming a novel approach for a more rapid diagnosis of heart attack in patients with acute ...

A test used by doctors in the emergency room to determine if a person is having a heart attack is now equipped to be more sensitive than ever. In addition to diagnosing heart attacks earlier, the test ...

A single high-sensitivity cardiac troponin T (hs-cTnT) test with findings below the level of detection, teamed with a nonischemic electrocardiogram (ECG), can identify patients with chest pain in the ...

Please provide your email address to receive an email when new articles are posted on . Introduction of a high-sensitivity troponin T test in Sweden led to an increased incidence of MI diagnosis, ...

A modified algorithm using a high-sensitivity cardiac troponin T (hs-cTnT) assay safely and rapidly ruled out more patients with myocardial infarction in one US emergency department, with more than ...

Cardiac troponin T is a protein biomarker detectable with a blood test, and it is the preferred biomarker for determining cardiovascular risk. In a new study published in JAMA Cardiology, researchers ...

Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is accurate at diagnosing heart attacks not only in men but also women. Recently ...